Company Filing History:
1 out of 23 
1 out of 5,101 
1 out of 4 Years Active: 2020
Title: Barbara Polski: Innovator in Membranous Nephropathy Research
Introduction
Barbara Polski is a notable inventor based in La Trinité, France. She has made significant contributions to the field of medical research, particularly in the area of nephrology. Her innovative work has led to the development of a unique method for assessing the prognosis of idiopathic membranous nephropathy.
Latest Patents
Barbara Polski holds one patent titled "Prognosis and monitoring of membranous nephropathy based on the analysis of PLA2R1 epitope profile." This patent discloses a method for evaluating the prognosis of idiopathic membranous nephropathy using a body fluid sample from a human subject. The method focuses on profiling PLA2R1 epitopes recognized by autoantibodies in the sample. It also involves analyzing PLA2R1 epitope spreading among three PLA2R1 domains, which are recognized by anti-PLA2R1 autoantibodies. Notably, two of these domains are closely associated with active idiopathic membranous nephropathy and are likely linked by a mechanism of epitope spreading.
Career Highlights
Throughout her career, Barbara has worked with esteemed institutions such as Université de Nice Sophia Antipolis and the Centre National de la Recherche Scientifique. Her research has been pivotal in advancing the understanding of membranous nephropathy and its implications for patient prognosis.
Collaborations
Barbara has collaborated with notable colleagues, including Vincent Louis Marie Esnault and Gérard Jean Frantz Lambeau. Their combined expertise has contributed to the success of her research endeavors.
Conclusion
Barbara Polski's innovative work in the field of nephrology exemplifies the impact of research on medical science. Her contributions continue to influence the understanding and treatment of membranous nephropathy.